Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mahon

Showing results (341-350 of 351) with videos related to

Pageof 36
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Quantifying and imaging NY-ESO-1/LAGE-1-derived epitopes on tumor cells using high affinity T cell receptorsMarco A Purbhoo, Deborah H Sutton, Joanna E Brewer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functionsPaul F Robbins, Yong F Li, Mona El-Gamil, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 18, 2024
Quality-of-Life Analysis of a Phase II Randomised Controlled Trial Comparing Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy in Locally Advanced Rectal CancerR L Geary, C Gillham, G McVey, et al.
Immunotherapy Advances|December 11, 2024
High-affinity T cell receptor ImmTAC® bispecific efficiently redirects T cells to kill tumor cells expressing the cancer-testis antigen PRAMEAna R Ribeiro, Camille Britton-Rivet, Laura Collins, et al.
Journal of Molecular Biology|February 23, 2013
Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potentialCiara M Mahon, Matthew A Lambert, Jacob Glanville, et al.
Journal of Molecular Biology|March 17, 2009
Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regionsWilliam J Finlay, Orla Cunningham, Matthew A Lambert, et al.
Cancer Journal (Sudbury, Mass.)|July 24, 2019
Adverse Events in Genetic Testing: The Fourth Case SeriesMeagan B Farmer, Danielle C Bonadies, Suzanne M Mahon, et al.
Science Advances|April 1, 2026
Beta cell-targeted PD-1 agonist inhibits cell-mediated autoimmunity in pancreas tissue slicesMatthew W Becker, Matthew E Brown, Katherine Wiseman, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Inhibition of cell-mediated immunity in type 1 diabetes by beta cell-targeted PD-1 agonists in pancreas tissue slicesMatthew W Becker, Matthew Brown, Katherine Wiseman, et al.
JCI Insight|September 7, 2021
Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitorsAdam P Curnock, Giovanna Bossi, Jyothi Kumaran, et al.
Pageof 36

Showing results (341-350 of 351) with videos related to

Sort By:
Pageof 36
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Quantifying and imaging NY-ESO-1/LAGE-1-derived epitopes on tumor cells using high affinity T cell receptorsMarco A Purbhoo, Deborah H Sutton, Joanna E Brewer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functionsPaul F Robbins, Yong F Li, Mona El-Gamil, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 18, 2024
Quality-of-Life Analysis of a Phase II Randomised Controlled Trial Comparing Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy in Locally Advanced Rectal CancerR L Geary, C Gillham, G McVey, et al.
Immunotherapy Advances|December 11, 2024
High-affinity T cell receptor ImmTAC® bispecific efficiently redirects T cells to kill tumor cells expressing the cancer-testis antigen PRAMEAna R Ribeiro, Camille Britton-Rivet, Laura Collins, et al.
Journal of Molecular Biology|February 23, 2013
Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potentialCiara M Mahon, Matthew A Lambert, Jacob Glanville, et al.
Journal of Molecular Biology|March 17, 2009
Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regionsWilliam J Finlay, Orla Cunningham, Matthew A Lambert, et al.
Cancer Journal (Sudbury, Mass.)|July 24, 2019
Adverse Events in Genetic Testing: The Fourth Case SeriesMeagan B Farmer, Danielle C Bonadies, Suzanne M Mahon, et al.
Science Advances|April 1, 2026
Beta cell-targeted PD-1 agonist inhibits cell-mediated autoimmunity in pancreas tissue slicesMatthew W Becker, Matthew E Brown, Katherine Wiseman, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Inhibition of cell-mediated immunity in type 1 diabetes by beta cell-targeted PD-1 agonists in pancreas tissue slicesMatthew W Becker, Matthew Brown, Katherine Wiseman, et al.
JCI Insight|September 7, 2021
Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitorsAdam P Curnock, Giovanna Bossi, Jyothi Kumaran, et al.
Pageof 36